The most recent trading session ended with Pfizer (PFE) standing at $25.60, reflecting a -0.43% shift from the previouse trading day's closing. This change was narrower than the S&P 500's daily loss ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other best ...

All this negativity, however, does open up an opportunity for investors to buy the stock at a discount. Despite being a top company in the healthcare industry, investors are treating Pfizer as a ...

Guggenheim analyst Vamil Divan maintained a Buy rating on Pfizer (PFE – Research Report) yesterday. The company’s shares closed yesterday at ...

Pfizer's strong fundamentals, impressive R&D achievements, and undervalued metrics underscore its defensive appeal and growth ...

Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is ...

Discover the strengths & weaknesses of healthcare giants Johnson & Johnson and Pfizer. Find out which stock is more promising ...

Shrewd investors know that bear markets open up great opportunities to pick up shares of excellent companies from the ...

This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Pfizer is expected to post earnings of $0.64 per share ...

In a report released today, Kerry Holford from Berenberg Bank maintained a Hold rating on Pfizer (PFE – Research Report), with a price target ...